VOR vs VNDA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VOR Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vor Biopharma Inc. Common Stock (VOR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while VNDA counters with relative strength in Valuation. Fundamentally, VOR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VNDA at 103.1x Forward P/E and -77.6% operating margin (+24.1% YoY). In options structure, VOR sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against VNDA sits in BREAKDOWN (75th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VOR | VNDA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | $238.9M | Larger Scale | VOR |
| Trailing P/E Ratio Valuation | 0.1x | 103.1x | Lower Multiple | VOR |
| Forward P/E Ratio Valuation | N/M | 103.1x | Lower Multiple | VNDA |
| Revenue Growth (YoY) Growth | +0.0% | +24.1% | Higher Growth | VNDA |
| Operating Margin (TTM) Profitability | 0.0% | -77.6% | Higher Margin | VOR |
| Net Profit Margin Profitability | 0.0% | -119.9% | Higher Margin | VOR |
| Return on Equity (ROE) Capital Efficiency | -125.4% | -82.5% | Higher ROE | VNDA |
| 52-Week Range Position Momentum | 65% ($6โ$26) | 4% ($4โ$10) | Stronger Trend | VOR |
| Beta / 30D Volatility Risk Regime | 1.91ฮฒ ยท 61% Vol | 1.25ฮฒ ยท 61% Vol | Lower Realized Risk | VOR |
| Unified Institutional Score Composite Signal | 57.8 / 100 (HOLD) | 49.0 / 100 (HOLD) | Higher Composite | VOR |